期刊文献+

增强PIAS3表达对CHG-5细胞生物学效应的影响 被引量:1

Effects of the overexpression of PIAS3 in CHG-5 glioma cells in vitro
原文传递
导出
摘要 目的探讨增强人胶质瘤CHG-5细胞内的活化STAT3抑制蛋白(protein inhibitor of activated STAT3,PIAS3)表达对CHG-5细胞增殖及凋亡等生物学效应的影响。方法构建PIAS3真核表达载体pEGFP-N1-PIAS3,使用脂质体法瞬时转染人CHG-5胶质瘤细胞,同时设置空白对照组和阴性对照组,转染48h后用RT-PCR、蛋白质印迹法和免疫组化法分别在核酸和蛋白水平检测目的蛋白表达,采用流式细胞技术检测转染后的胶质瘤细胞凋亡和细胞增殖变化。结果转染后的CHG-5细胞可见PIAS3绿色荧光蛋白表达,显微镜观察发现细胞形态改变,坏死细胞增多。转染组PIAS3mRNA的积分密度值为523 414.50±34 502.89,与空白对照组的135 668.00±6 693.66和阴性对照组的154 511.67±8 266.89相比,转染组PIAS3mRNA表达增强,χ2=13.053,P=0.01。转染组PIAS3蛋白的积分密度值为30.13±3.76,与空白对照组的13.83±0.77和阴性对照组的15.02±0.87比较,CHG-5细胞转染PIAS3基因后,PIAS3蛋白表达增强,χ2=14.193,P=0.001。提示转染后PIAS3mRNA和蛋白表达增加。转染组的早期细胞凋亡率为(12.5±1.9)%,较空白对照组的(6.4±1.1)%和阴性对照组的(5.4±1.8)%升高,χ2=7.407,P=0.005;转染组的活细胞率为(86.9±2.2)%,较空白对照组的(92.1±1.2)%和阴性对照组的(93.1±2.0)%降低,χ2=4.775,P=0.019。转染组S期细胞百分率为(35.2±4.2)%,高于空白对照组的(24.5±5.1)%和阴性对照组的(23.0±3.7)%,χ2=8.179,P=0.003;转染组G2期细胞百分率为(10.7±5.4)%,高于空白对照组的(21.3±4.0)%和阴性对照组的(27.8±5.2)%,χ2=17.121,P<0.01。结论外源性增强PIAS3表达,引起CHG-5胶质瘤细胞生长缓慢,出现S期阻滞,并促进细胞凋亡发生。 OBJECTIVE To observe the effects of overexpression of protein inhibitor of activated STAT3(PIAS3) on the proliferation and apoptosis in CHG-5 glioma cells. METHODS The constructed eukaryotic expression vectors of PIAS3 was constructed named as pEGFP-N1-PIAS3. In vitro the CHG-5 glioma cells were transfected with pEGFP-N1-PIAS3 with O1- igofectamine. At the same time, the blank control and negative control groups were set. After 48 hours,the expression of PIAS3 was analyzed by RT-PCR,western blots and immunohistochemistry. The apoptosis and proliferation of the trans- fected cells were analyzed by flow cytometry. RESULTS The expression of PIAS3 in the transfected cells was increased. The change of cell shape and increased necrotic cells were observed by microscope. The IDV (Integrated density value) of PIAS3 mRNA (523 414.5±34 502.89) in the PIAS3-transfected group was significantly different from that of the blank control group (135 668.0±6 693.66) and the negative control group (154 511.67±8 266.89;x^2 =13. 053,P=0.01).The IDV of PIAS3 protein (30. 13 ±3.76) in the PIAS3-transfected group was significantly different from that of the blank control group (13.83±0. 77) and the negative control group (15.02 ± 0.87;x^2 = 14. 193, P= 0. 001). The results suggested that the expression of PIAS3 was increased in the PIAS3-transfected cells. The percentage of early apoptotic cells (12. 5 ±1.9)% in the PIAS3-transfeeted group was significantly higher than that of the blank control group (6.4 ± 1.1)% and the negative control group (5.4±1.8)% (x^2=7. 407,P=0. 005). The rate of living cells (86.9±2.2)G was significantly lower than that of the blank control group (92.1 ± 1.2) % and the negative control group (93.1 ± 2.0) (x^2 =4. 775,P=0.019). The percentage of the cells in S phase (35.2±4.2)% in the PIAS3-transfected group was sig- nificantly higher than that of the blank control group (24.5 ±5.1 ) % and the negative control group (23.0± 3.7) % (x^2 = 8. 179,P=0. 003). The percentage of the cells in Gz phase (10.7±5.4)% in the PIAS3-transfected group was signifi- cantly lower than that of the blank control group (21.3±4.0)% and the negative control group (27.8±5.2)% ( x^2 = 17. 121,P〈0. 01). CONCLUSION The overexpression of PIAS3 in CHG-5 glioma cells significantly suppresses cells proliferation, induces S-phase arrest and cell apoptosis.
出处 《中华肿瘤防治杂志》 CAS 北大核心 2015年第17期1341-1346,共6页 Chinese Journal of Cancer Prevention and Treatment
基金 国家自然科学基金(30973074)
关键词 PIAS3 胶质瘤细胞 增殖 细胞周期 凋亡 PIAS3 glioma cell proliferation cell cycle apoptosis
  • 相关文献

参考文献22

  • 1Palvimo JJ. PIAS proteins as regulators of small ubiquitin-relat- ed modifier (SUMO) modifications and transcription[J]. Bio- chem Soc Trans, 2007,35 (6) : 1405-1408.
  • 2Spitzner M, Ebner R, Wolff HA, et al. STAT3: A novel mo- lecular mediator of resistance to chemoradiotherapy[J]. Canc- ers, 2014,6(4) .. 1986-2011.
  • 3Liu S, Fan Z, Geng Z, et al. PIAS3 promotes homology-direct- ed repair and distal non-homologous end joining[J]. Oncol Lett, 2013,6(4) .. 1045-1048.
  • 4陈自强,卞修武,辛榕,殷育松.人脑胶质瘤细胞系CHG-5的建立及其生物学特性的分析[J].第三军医大学学报,1999,21(12):880-883. 被引量:15
  • 5Furqan M, Mukhi N, Lee B, et al. Dysregulation of JAK-STAT pathway in hematological malignancies and JAK inhibitors for clinical applieation[J]. Biomark Res, 2013,1 (1) : 5.
  • 6Rytinki MM, Kaikkonen S, Pehkonen P, et al. PIAS proteins: pleiotropic interactors associated with SUMO[J]. Cell Mol Life Sci, 2009,66 (18) : 3029-3041.
  • 7Zlatanou A, Stewart GS. A PIAS-ed view of DNA double strand break repair focuses on SUMO[J]. DNA Repair, 2010, 9 (5) 588-592.
  • 8Pastuszak-Lewandoska D, Domafiska D, Czarnecka KH, et al. Expression of STAT5, COX-2 and PIAS3 in correlation with NSCLC histhopathological features[J/CD]. PLoS One, 2014, 9 (8) :e104265.
  • 9Li H, Gao H, Bijukchhe SM, et al. PIAS3 may represent a po- tential biomarker for diagnosis and therapeutic of human eolorec- tal cancer[J]. Med Hypotheses,2013,81(6)1151-1154.
  • 10Wu W, Takanashi M, Borjigin N, et al. MicroRNA-18a modu- lates STAT3 activity through negative regulation of PIAS3 dur- ing gastric adenocarcino-genesis[J]. Br J Cancer, 2013,108(3) .. 653-661.

二级参考文献19

  • 1杜子威 徐庚达 等.人脑恶性胶质瘤细胞体外长期传代培养的研究[J].江苏医药,1983,3(8):2-4.
  • 2司徒镇强,细胞培养,1996年,69页
  • 3杜子威,江苏医药,1983年,3卷,8期,2页
  • 4Shuai K,Liu B. Regulation of gene-activation pathways by PIAS proteins in the immune system[J].{H}Nature reviews Immunology,2005,(08):593-605.
  • 5Yagil Z,Nechushtan H,Kay G. The enigma of the role of pro-tein inhibitor of activated STAT3(PIAS3)in the immune response[J].{H}Trends in Immunology,2010,(05):199-204.
  • 6Wang L,Banejee S. Differential PIAS3 expression in human malig-nancy[J].{H}Oncology Reports,2004,(06):1319-1324.
  • 7Chen Ziqiang,Bian Xiuwu,Xin Rong. Establishment of hu-man glioma cellCHG-5 and its biological features[J].Journal of Third Military Medical University,1999,(12):880-883.
  • 8Borghouts C,Tittmann H,Delis N. The intracellular delivery of a recombinant peptide derived from the acidic domain of PIAS3 inhibits STAT3 transactivation and induces tumor celldeath[J].{H}Molecular Cancer Research,2010,(04):539-553.
  • 9Fernando JJ,Ryan JJ. Mast cellhomeostasis and the JAK-STAT pathway[J].{H}Genes and Immunity,2010,(08):599-608.
  • 10Mascle XH,Lussier-Price M,Cappadocia L. Identification of a non-covalent ternary complex formed by PIAS1,SUMO1,and UBC9 proteins involved in transcriptional regulation[J].{H}Journal of Biological Chemistry,2013,(51):36312-36327.

共引文献15

同被引文献7

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部